Updates to Medgenics’ Representations and Warranties in License Agreements. Notice of Changes to Medgenics In-License. On the date on which Medgenics provides the Initial Study Report to KHK pursuant to Section 2.5.2, Medgenics will provide KHK with written updates to Section 12.4 of the license agreement attached hereto as Exhibit B and Section 12.4 of the license agreement attached hereto as Exhibit C concerning any event, condition, fact or circumstance occurring after the CDOA Effective Date that would make Medgenics’ representations and warranties set forth in Section 12.4 of the license agreement attached hereto as Exhibit B and Section 12.4 of the license agreement attached hereto as Exhibit C untrue or incorrect when made as of the date on which Medgenics provides such update to KHK. All such written updates are collectively referred to as the “Medgenics Disclosure Schedule Updates.” On the date on which Medgenics provides the Initial Study Report to KHK pursuant to Section 2.5.2, Medgenics will also provide KHK with written notice of any amendment to the Medgenics In-License that would have a material impact on this Agreement, which notice will provide the substance of any such amendment.
